Our clients
Having worked in healthcare and financial sectors for many years, we have built up a formidable client base including pharmaceutical giants such as AstraZeneca, GlaxoSmithKline, Lilly, Pfizer and many others. Due to the unique power of the Eularis 94.8 ® tools, we are also sought out by pharmaceutical financial analysts and Venture Capitalist investing in this field, to assist with stock recommendations and predictions.
Questions?
One of our operators is standing by to chat to you in real time.
> Chat to us now
“Dr. Bates has produced a most valuable resource in the battle to improve patient adherence to medication. Her thorough analysis of the root causes and multi-faceted impact of patient non-adherence are backed up with a strong accessible reference set. There is no hiding from the data and Dr. Bates carefully structures a case for fact-based reconsideration of our (the Pharmaceutical Industry's) abilities to tackle this huge challenge head-on.
At InfoMedics, we find this an invaluable reference guide when engaged in strategic planning work with Pharmaceutical customers. I am of the strong opinion that readers of this report will be significantly wiser after reading it and better armed to design effective and profitable adherence strategies for their companies.”
Michael R. Ball, Ph.D, VP Marketing and Product Management, InfoMedics Inc.